Combined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth
American Journal of Physiology-Cell Physiology · 01.08.2025 · 329 (2) · C540-C559
DOI: 10.1152/ajpcell.00966.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.08.2025. Verfasst von Aino Männistö und 14 weiteren Autor:innen. Beteiligte Einrichtung: Wihuri Research Institute, Helsinki, Finland. Hauptthemen laut MEDLINE: Genetic Therapy, Muscle, Skeletal, Neovascularization, Physiologic, Myostatin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: WRI | Jenny ja Antti Wihurin Rahasto (Jenny JA Antti Wihurin Rahasto sr), Research Council of Finland (AKA), Sydäntutkimussäätiö (Finnish Foundation for Cardiovascular Research).
Abstract (Originalsprache)
We used intramuscular and systemic adeno-associated viral vector (AAV) gene delivery of myostatin propeptide (Pro-MSTN) and vascular endothelial growth factor B (VEGF-B) to induce muscle growth and angiogenesis in skeletal muscle. The intramuscular delivery of VEGF-B and Pro-MSTN in combination enhanced skeletal muscle growth and rescued vascularization when compared with Pro-MSTN alone. Single-cell RNA sequencing data showed that the treatments had the greatest effect on endothelial cells and pericytes. The combination treatment also improved body composition and muscle mass in diabetic mice, when delivered systemically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wihuri Research Institute, Helsinki, Finland.
- Stem Cell and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.
- Neuroscience Center, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
- Department of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
ORCID-Profile: Kialiina Tonttila, Harri Nurmi, Liina Uusitalo-Kylmälä, Tuuli A Nissinen, Arja Pasternack, Olli Ritvos, Kari Kustaa Alitalo, Juha J Hulmi, Riikka Kivelä
Förderung
- WRI | Jenny ja Antti Wihurin Rahasto (Jenny JA Antti Wihurin Rahasto sr)
- Research Council of Finland (AKA)
- Sydäntutkimussäätiö (Finnish Foundation for Cardiovascular Research)
- Sigrid Juséliuksen Säätiö (Sigrid Jusélius Stiftelse)
Zitieren
APA
Männistö, A., Tonttila, K., Ortega-Alonso, A., Nurmi, H., Uusitalo-Kylmälä, L., Amudhala Hemanthakumar, K., Saikkala, E., Myllykangas, S., Vertainen, S., Nissinen, T. A., Pasternack, A., Ritvos, O., Alitalo, K. K., Hulmi, J. J., & Kivelä, R. (2025). Combined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth. American Journal of Physiology-Cell Physiology, 329(2), C540-C559. https://doi.org/10.1152/ajpcell.00966.2024
Vancouver
Männistö A, Tonttila K, Ortega-Alonso A, Nurmi H, Uusitalo-Kylmälä L, Amudhala Hemanthakumar K, et al. Combined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth. American Journal of Physiology-Cell Physiology. 2025;329(2):C540-C559. doi:10.1152/ajpcell.00966.2024
BibTeX
@article{Mnnist2025,
author = {Männistö, Aino and Tonttila, Kialiina and Ortega-Alonso, Alfredo and Nurmi, Harri and Uusitalo-Kylmälä, Liina and Amudhala Hemanthakumar, Karthik and Saikkala, Erik and Myllykangas, Sami and Vertainen, Satu and Nissinen, Tuuli A and Pasternack, Arja and Ritvos, Olli and Alitalo, Kari Kustaa and Hulmi, Juha J and Kivelä, Riikka},
title = {Combined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
volume = {329},
number = {2},
pages = {C540--C559},
doi = {10.1152/ajpcell.00966.2024}
}
EUVIMED